Beacon Investment Advisory Services Inc. Sells 200 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Beacon Investment Advisory Services Inc. trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 8.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,150 shares of the financial services provider’s stock after selling 200 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in iShares Biotechnology ETF were worth $284,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Security National Bank of SO Dak lifted its holdings in iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares during the last quarter. SPC Financial Inc. increased its holdings in shares of iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after purchasing an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management raised its position in shares of iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares during the period. Capital Investment Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 1.0% during the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after buying an additional 99 shares during the last quarter. Finally, Magnus Financial Group LLC boosted its holdings in shares of iShares Biotechnology ETF by 0.8% during the 4th quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock worth $1,714,000 after buying an additional 104 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $138.25 on Friday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The company’s 50-day moving average price is $135.97 and its two-hundred day moving average price is $141.78.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.